This panel brings together executives that are each taking new approaches to treating neurodegenerative disorders. Attendees can expect the session to center around the current challenges in neurodegenerative disease treatment and the anticipated next steps in global research. Moderator: Danielle Friend, PhD, Senior Director, Science and Regulatory Affairs, BIO Speakers: Tor-Kristian Jenssen, Head, Research & Development, PubGene Peter Laivins, Chief Commercial Officer, Alzheon Professor Charalampos Tzoulis, Prof. of Neurology & Neurogenetics, Neuro-SysMed

Watch our webinar live or sign up for the recording to: Get an overview of the event, including a sneak preview into who’s coming and the plenary session Discover the ins and outs of virtual partnering See a walk-through of the One-on-One Partnering platform and its key features Q&A session